PHARMACOLOGIC AMPK ACTIVATION IMPROVES HEALTHSPAN AND LIFESPAN IN NORMAL AND PREMATURE AGING MODELS
Ozlem Altintas Akin, Sarah Mitchell, Shana Sturla, Michael MacArthur · 2023
Read PHARMACOLOGIC AMPK ACTIVATION IMPROVES HEALTHSPAN AND LIFESPAN IN NORMAL AND PREMATURE AGING MODELS by Ozlem Altintas Akin, Sarah Mitchell, Shana Sturla, Michael MacArthur (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10737212.txt.
Description
Ozlem Altintas Akin, Sarah Mitchell, Shana Sturla, and Michael MacArthur test a drug that switches on a cell energy sensor in aging models in two thousand twenty-three. Cockayne Syndrome, a rare childhood disorder of faulty DNA repair, ages children fast. The sensor, AMPK, may run weak when the repair genes fail.
The drug MK-8722, an AMPK activator, lengthened life in normal worms and in a worm model of the syndrome. It left brood size, a fitness gauge, unchanged. In aged mice, the same drug improved body composition, grip strength, and age-linked inflammation. The team reads this as a hint that AMPK drugs could aid both ordinary aging and the syndrome's fast track.
Catalog record
| CREATOR | Ozlem Altintas Akin, Sarah Mitchell, Shana Sturla, Michael MacArthur |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 1 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |